UNSPSC 85819226: Transfusion of nonautologous hematopoietic stem cells into peripheral artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous hematopoietic stem cells into peripheral artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30250Y1

UNSPSC 85819226 Transfusion of nonautologous hematopoietic stem cells into peripheral artery, open approach is a Commodity code that shows little relevant recent activity under its literal scope. The six recent state and local solicitations tagged with this code do not procure hematopoietic stem cell transfusions or related cellular therapies. Instead, the opportunities span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out networks, and emergency medical services for youth in custody — a divergence between the code's nominal scope and what is actually being bought that suggests either systematic miscoding by issuing bodies or the code's use as a catch-all for medical services that do not fit more specific classifications. The issuing bodies include state agencies (Washington State Department of Transportation), county health systems and probation departments (Harris County, Collier County, Santa Clara County), city retirement offices (Phoenix), and municipal government (Long Beach), reflecting the broad range of state and local healthcare purchasers. None of the opportunities directly relate to stem cell transfusions or hematopoietic stem cell transplantation.

The geographic spread of these miscoded opportunities spans Washington, Arizona, California, Florida, and Texas. Representative solicitations include the Washington State Department of Transportation's RFP for occupational medical surveillance services (pre-bid conference August 31, 2026; proposals due October 9, 2026), the City of Phoenix Retirement Office's RFP for independent medical evaluation services supporting disability benefit determinations (proposals due October 16, 2026; $750,000 maximum compensation over five years), the City of Long Beach's RFP for surgical and medical procedure carve-out benefits (proposals due October 7, 2026; contract execution targeted for April 1, 2027), and Collier County's RFP for pharmacy benefit management services (proposals due April 9, 2026; historical annual pharmacy spending approximately $8.7 million). The code's current tagging appears to reflect issuing-body coding practices rather than procurement activity genuinely aligned with hematopoietic stem cell therapies. Business development professionals should verify whether opportunities genuinely matching the code's scope exist elsewhere or treat this code as inactive for state and local purposes.